— Know what they know.
Not Investment Advice

GNLKQ OTC

GeneLink, Inc.
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: +0.0% 1Y: +0.0% 3Y: -60.0% 5Y: -95.6%
$0.00
+0.00 (+0.00%)
 
OTC · Healthcare · Biotechnology · Tech Score Neutral · Power 50 · $10601 mcap · 161M float · 0.0003% daily turnover

Balance Sheet Trends

Total Assets
$1M -47.7% ▼
5Y CAGR: +1.0%
Total Liabilities
$4M -3.4% ▼
5Y CAGR: +28.2%
Shareholders Equity
-$3M -79.7% ▼
Cash & Investments
$158K -78.6% ▼
5Y CAGR: -30.4%
Total Debt
$0 +0.0% ▲
Net Debt
-$158K +78.6% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2008FY2009FY2010FY2011FY2012
— Assets —
Cash$435K$197K$429K$741K$158K
Short-Term Investments$0$0$0$0$0
Cash & ST Investments$435K$197K$429K$741K$158K
Net Receivables$714K$466K$306K$235K$78K
Inventory$740K$495K$224K$562K$394K
Other Current Assets$0$0$0$0$0
Total Current Assets$2M$1M$1M$2M$772K
Property, Plant & Equip.$282K$303K$256K$168K$258K
Goodwill & Intangibles$0$0$241K$236K$55K
Long-Term Investments$0$0$0$0$0
Other Non-Current Assets$321K$279K$179K$517K$370K
Total Non-Current Assets$603K$582K$676K$920K$683K
Total Assets$3M$2M$2M$3M$1M
— Liabilities —
Accounts Payable$2M$1M$860K$1M$1M
Short-Term Debt$60K$36K$28K$0$0
Deferred Revenue$162K$277K$156K$208K$171K
Other Current Liabilities$219K$206K$180K$299K$35K
Total Current Liabilities$2M$2M$2M$2M$2M
Long-Term Debt$0$0$0$0$0
Other Non-Current Liab.$0$893K$851K$2M$2M
Total Non-Current Liabilities$0$893K$851K$2M$2M
Total Liabilities$2M$3M$3M$4M$4M
— Equity —
Common Stock$1M$1M$2M$2M$3M
Retained Earnings-$15M-$18M-$21M-$25M-$28M
Accumulated OCI$0$0$0$0$0
Total Stockholders Equity$52K-$740K-$790K-$1M-$3M
Total Liabilities & Equity$3M$2M$2M$3M$1M
— Key Metrics —
Total Debt$60K$36K$28K$0$0
Net Debt-$375K-$161K-$402K-$741K-$158K
Total Investments$0$0$0$0$0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms